To: | 4medica, Inc. (ch.tm@dlapiper.com) |
Subject: | U.S. Trademark Application Serial No. 88336715 - 4MEDICA BIG DATA MPI - 425437-4 |
Sent: | July 13, 2020 11:02:23 AM |
Sent As: | ecom112@uspto.gov |
Attachments: | Attachment - 1 Attachment - 2 Attachment - 3 Attachment - 4 Attachment - 5 Attachment - 6 Attachment - 7 Attachment - 8 Attachment - 9 Attachment - 10 Attachment - 11 Attachment - 12 Attachment - 13 Attachment - 14 Attachment - 15 Attachment - 16 Attachment - 17 Attachment - 18 Attachment - 19 Attachment - 20 Attachment - 21 Attachment - 22 Attachment - 23 Attachment - 24 Attachment - 25 Attachment - 26 Attachment - 27 Attachment - 28 |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88336715
Mark: 4MEDICA BIG DATA MPI
|
|
Correspondence Address:
|
|
Applicant: 4medica, Inc.
|
|
Reference/Docket No. 425437-4
Correspondence Email Address: |
|
NONFINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: July 13, 2020
This Office action is in response to applicant’s communication filed on 6/14/2020.
SECTION 2(f) ACQUIRED DISTINCTIVENESS
Applicant has asserted a claim of acquired distinctiveness in part as to BIG DATA MPI under Trademark Act Section 2(f) based on use of this wording in commerce with the associated services for five years prior to the date on which the claim is made. See 15 U.S.C. §1052(f). In support thereof, applicant has provided an affidavit from Gregg Church, President of Applicant, as well as evidence of advertising, use and promotion of the of the phrase BIG DATA MPI to “demonstrate that the relevant public understands the primary significance” of this phrase “as identifying the source of Applicant’s services”. See Response. Such evidence is, however, not dispositive of an applicant’s claim of distinctiveness. See 15 U.S.C. §1052(f). Evidence of advertising and promotion may demonstrate applicant’s efforts to develop distinctiveness; but does not establish that the mark has actually acquired distinctiveness. See In re Pennzoil Prods. Co., 20 USPQ2d 1753, 1757-58 (TTAB 1991).
Moreover, the Office has determined that the allegation of five years’ use is insufficient to show acquired distinctiveness in this case because, as shown by the attached evidence and evidence previously made of record, the wording “BIG DATA MPI” appears to be generic in the context of applicant’s services. See In re La. Fish Fry Prods., Ltd., 797 F.3d 1332, 1336-37, 116 USPQ2d 1262, 1265 (Fed. Cir. 2015); In re Virtual Indep. Paralegals, LLC, 2019 USPQ2d 111512, at *11-12 (TTAB 2019); TMEP §1212.05(a). “Big Data” is the designation for a large volume of structured and unstructured data and “MPI” is an acronym for “master patient index”. See attached definitions.
(1) What is the genus of goods and/or services at issue?
(2) Does the relevant public understand the designation primarily to refer to that genus of goods and/or services?
In re Cordua Rests., Inc., 823 F.3d 594, 599, 118 USPQ2d 1632, 1634 (Fed. Cir. 2016) (citing H. Marvin Ginn Corp. v. Int’l Ass’n of Fire Chiefs, Inc., 782 F.2d 987, 990, 228 USPQ 528, 530 (Fed. Cir. 1986)); TMEP §1209.01(c)(i).
Regarding the first part of the inquiry, the genus of the services may be defined by an applicant’s identification. See In re Cordua Rests., Inc., 823 F.3d at 602, 118 USPQ2d at 1636 (citing Magic Wand Inc. v. RDB Inc., 940 F.2d at 640, 19 USPQ2d at 1552); see also In re 1800Mattress.com IP, LLC, 586 F.3d 1359, 1361, 1363, 92 USPQ2d 1682, 1682, 1684 (Fed. Cir. 2009).
In this case, the application identifies the services as “software in the field of healthcare for the purposes of collection, editing, organizing, modifying, book marking, storage, sharing, processing, and transmission of electronic health records; software as a service (SaaS) services featuring software for application and database integration in the healthcare field; software as a service (SaaS) services featuring software for controlling and managing patient medical information”; which adequately defines the genus at issue.
Regarding the second part of the inquiry, the relevant public is the purchasing or consuming public for the identified goods and/or services. The Loglan Inst. Inc. v. The Logical Language Grp., 962 F.2d 1038, 1041, 22 USPQ2d 1531, 1533 (Fed. Cir. 1992) (quoting Magic Wand Inc. v. RDB Inc., 940 F.2d at 640, 19 USPQ2d at 1553). In this case, the relevant public comprises healthcare organizations who purchase applicant’s software for collection, editing, organizing, modifying, book marking, storage, sharing, processing, and transmission of big data in the healthcare field and for use in managing patient medical information, because there are no restrictions or limitations to the channels of trade or classes of consumers. The attached evidence shows that this relevant public would understand that the wording “big data mpi” in the applied-for mark to refer primarily to that genus of services.
Applicant may respond by submitting a disclaimer in the following format:
No claim is made to the exclusive right to use “BIG DATA MPI” apart from the mark as shown.
TMEP §1213.08(a)(i).
To expedite approval, applicant is invited call or email the assigned trademark examining attorney to authorize entry of the required disclaimer via EXAMINER’S AMENDMENT.
How to respond. Click to file a response to this nonfinal Office action.
Kimberly Boulware Perry
/Kimberly Boulware Perry/
Trademark Attorney, Law Office 112
571-272-9208 (direct)
kimberly.perry@uspto.gov
RESPONSE GUIDANCE